Correlation Between Syndax Pharmaceuticals and RAPT Therapeutics
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and RAPT Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and RAPT Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and RAPT Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and RAPT Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of RAPT Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and RAPT Therapeutics.
Diversification Opportunities for Syndax Pharmaceuticals and RAPT Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Syndax and RAPT is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and RAPT Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAPT Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with RAPT Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAPT Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and RAPT Therapeutics go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and RAPT Therapeutics
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 0.56 times more return on investment than RAPT Therapeutics. However, Syndax Pharmaceuticals is 1.79 times less risky than RAPT Therapeutics. It trades about -0.06 of its potential returns per unit of risk. RAPT Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 1,894 in Syndax Pharmaceuticals on September 3, 2024 and sell it today you would lose (222.00) from holding Syndax Pharmaceuticals or give up 11.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. RAPT Therapeutics
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| RAPT Therapeutics |
Syndax Pharmaceuticals and RAPT Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and RAPT Therapeutics
The main advantage of trading using opposite Syndax Pharmaceuticals and RAPT Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, RAPT Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will offset losses from the drop in RAPT Therapeutics' long position.| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
| RAPT Therapeutics vs. DiaMedica Therapeutics | RAPT Therapeutics vs. Lyra Therapeutics | RAPT Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |